Novel Amblyopia Treatment With Virtual Reality Games
Conditions: Amblyopia Interventions: Device: Optical Correction; Device: Therapeutic Dichoptic Virtual Reality Games Sponsors: Marjean Kulp; Beta Sigma Kappa - College of Optometrists in Vision Development; VividVision Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the Presbyopia
Conditions: Presbyopia; Near Vision; Miosis; Eye Diseases Interventions: Drug: Aceclidine+Brimonidine combination ophthalmic solution; Drug: Aceclidine ophthalmic solution; Drug: Placebo (Vehicle) ophthalmic solution Sponsors: Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.; LENZ Therapeutics, Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
Normative Database of Healthy Subject Vascular Density Using Spectralis Heidelberg ® Optical Coherence Tomography Angiography
Conditions: Optical Coherence Tomography; Optical Coherence Tomography Angiography Interventions: Other: Optical coherence tomography angiography; Other: ophthalmological exam Sponsors: Centre Hospitalier Universitaire, Amiens; GHPSO de Creil; Hôpital Saint Vincent de Paul, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2023 Category: Research Source Type: clinical trials
